Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 27, 2025, Eagle Pharmaceuticals (EGRX) has a market cap of $22.029 million USD. According to our data, Eagle Pharmaceuticals is ranked No.8542 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 27, 2025 | $22.03 M |
240.00%
|
| Dec 31, 2024 | $6.48 M |
-90.44%
|
| Dec 29, 2023 | $67.77 M |
-82.11%
|
| Dec 30, 2022 | $0.38 B |
-42.60%
|
| Dec 31, 2021 | $0.66 B |
9.34%
|
| Dec 31, 2020 | $0.60 B |
-22.49%
|
| Dec 31, 2019 | $0.78 B |
49.12%
|
| Dec 31, 2018 | $0.52 B |
-24.58%
|
| Dec 29, 2017 | $0.69 B |
-32.67%
|
| Dec 30, 2016 | $1.03 B |
-10.52%
|
| Dec 31, 2015 | $1.15 B |
472.06%
|
| Dec 31, 2014 | $0.20 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Amgen
AMGN
|
$150.87 B |
0.008 M
|
USA
|
 Teva Pharmaceutical Industries
TEVA
|
$17.06 B |
0.000 M
|
Israel
|
 Pfizer
PFE
|
$129.99 B |
0.003 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$99.09 B |
1.608 B
|
USA
|
 Eli Lilly
LLY
|
$794.31 B |
-0.030 M
|
USA
|
 Merck
MRK
|
$208.21 B |
-0.008 M
|
USA
|
 Johnson & Johnson
JNJ
|
$372.77 B |
0.842 B
|
USA
|
 Novartis
NVS
|
$221.49 B |
-0.001 M
|
Switzerland
|
 Sanofi
SNY
|
$129.11 B |
1.331 B
|
France
|
 GlaxoSmithKline
GSK
|
$75.79 B |
0.002 M
|
UK
|
 AstraZeneca
AZN
|
$215.69 B |
-0.006 M
|
UK
|
 AbbVie
ABBV
|
$329.14 B |
-0.002 M
|
USA
|
 Biogen
BIIB
|
$17.49 B |
98.043 M
|
USA
|
 Gilead Sciences
GILD
|
$132.33 B |
3.883 B
|
USA
|
| Market Cap | = | EGRX Stock Price | * | EGRX Shares Outstanding |
| = | $1.70 | * | 12.96 M | |
| = | $22.03 M |